Aquestive Therapeutics Ownership | Who Owns Aquestive Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Aquestive Therapeutics Ownership Summary


Aquestive Therapeutics is owned by 47.89% institutional investors, 4.39% insiders, and 47.72% retail investors. Bratton capital management is the largest institutional shareholder, holding 10.77% of AQST shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.43% of its assets in Aquestive Therapeutics shares.

AQST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAquestive Therapeutics47.89%4.39%47.72%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bratton capital management9.81M10.77%$34.93M
Blackrock5.45M7.41%$14.18M
Blackrock funding, inc. /de6.48M6.52%$21.44M
Vanguard group4.35M4.77%$15.47M
Perceptive advisors2.19M2.21%$7.25M
Geode capital management1.65M1.82%$5.89M
Pale fire capital se1.68M1.69%$5.55M
State street1.50M1.65%$5.35M
Janney montgomery scott880.49K1.20%$2.29M
Goldman sachs group876.54K0.96%$3.12M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bratton capital management9.81M100.00%$34.93M
Sio capital management947.49K1.20%$3.14M
Blue owl capital lp920.00K0.98%$3.05M
Latash investments243.13K0.62%$804.77K
Pale fire capital se1.68M0.57%$5.55M
Diametric capital, lp165.37K0.29%$547.38K
Perceptive advisors2.19M0.27%$7.25M
Harvey capital management333.75K0.27%$1.13M
Cahill wealth management143.05K0.26%$509.26K
Entrypoint capital149.16K0.25%$493.71K

Top Buyers

HolderShares% AssetsChange
Blackrock5.45M0.00%4.11M
Goldman sachs group876.54K0.00%653.85K
Sio capital management947.49K1.20%555.86K
Blackrock funding, inc. /de6.48M0.00%540.85K
Janney montgomery scott880.49K0.01%538.63K

Top Sellers

HolderShares% AssetsChange
Vr adviser---2.63M
Franklin resources---2.13M
Bioimpact capital---1.61M
Laurion capital management lp---1.55M
Perceptive advisors2.19M0.27%-1.54M

New Positions

HolderShares% AssetsChangeValue
Financial engines advisors272.69K0.00%272.69K$903.00K
Centiva capital, lp63.95K0.00%63.95K$211.68K
China universal asset management19.33K0.01%19.33K$68.83K
Daymark wealth partners17.50K0.00%17.50K$57.92K
First national bank & trust co of newtown15.00K0.01%15.00K$49.50K

Sold Out

HolderChange
National bank of canada /fi/-4.00
Ifp advisors-10.00
Coppell advisory solutions-16.00
True wealth design-47.00
Northwestern mutual wealth management-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025118-5.60%47,569,6177.50%472.23%66-9.59%26-13.33%
Mar 31, 20251255.93%44,252,8622.02%462.04%738.96%30-6.25%
Dec 31, 2024117-4.10%43,374,494-7.27%471.81%66-15.38%3233.33%
Sep 30, 202412223.23%46,774,77210.17%511.54%7931.67%23-
Jun 30, 202499-3.88%42,456,8902.32%571.26%60-18.92%2364.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.40M2.43%-
Vanguard Total Stock Mkt Idx Inv2.35M2.37%-52.26K
iShares Russell 2000 ETF2.05M2.06%-38.95K
Fidelity Small Cap Index861.98K0.87%108.98K
Vanguard Institutional Extnd Mkt Idx Tr855.73K0.86%-400.11K
Invesco Dorsey Wright SmallCap Momt ETF775.69K0.85%1.41K
Nuveen Equity Index R6649.35K0.71%-
Franklin Biotechnology Discv A(acc)USD521.70K0.57%-821.40K
MEDICAL BioHealth EUR Acc485.29K0.53%-
iShares Russell 2000 Value ETF491.19K0.49%364.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 04, 2025Jung Cassie Chief Operating OfficerSell$310.90K
Sep 05, 2025Boyd Peter E. See RemarksSell$79.50K
Nov 26, 2024Jung Cassie Chief Operating OfficerSell$214.06
Mar 15, 2024Schobel Alexander Mark Chief Innovation/Tech OfficerSell$300.00K
Mar 08, 2024Schobel Alexander Mark Chief Innovation/Tech OfficerSell$129.69K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4-1
2024 Q3--

AQST Ownership FAQ


Who Owns Aquestive Therapeutics?

Aquestive Therapeutics shareholders are primarily institutional investors at 47.89%, followed by 4.39% insiders and 47.72% retail investors. The average institutional ownership in Aquestive Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Aquestive Therapeutics exceeds.

Who owns the most shares of Aquestive Therapeutics?

Aquestive Therapeutics’s largest shareholders are Bratton capital management (9.81M shares, 10.77%), Blackrock (5.45M shares, 7.41%), and Blackrock funding, inc. /de (6.48M shares, 6.52%). Together, they hold 24.70% of Aquestive Therapeutics’s total shares outstanding.

Does Blackrock own Aquestive Therapeutics?

Yes, BlackRock owns 7.41% of Aquestive Therapeutics, totaling 5.45M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.18M$. In the last quarter, BlackRock increased its holdings by 4.11M shares, a 305.59% change.

Who is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested?

Bratton capital management is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 9.81M Aquestive Therapeutics shares, valued at 34.93M$.

Who is the top mutual fund holder of Aquestive Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Aquestive Therapeutics shares, with 2.43% of its total shares outstanding invested in 2.4M Aquestive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools